Coadministered Amlodipine and Atorvastatin Produces Early Improvements in Arterial Wall Compliance in Hypertensive Patients With Dyslipidemia
Author(s) -
Jay N. Cohn,
Daniel J. Wilson,
J NEUTEL,
Mark C. Houston,
M H Weinberger,
Richard H. Grimm,
David H.G. Smith,
William Sun
Publication year - 2008
Publication title -
american journal of hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.009
H-Index - 136
eISSN - 1941-7225
pISSN - 0895-7061
DOI - 10.1038/ajh.2008.325
Subject(s) - atorvastatin , amlodipine , medicine , dyslipidemia , placebo , blood pressure , randomized controlled trial , pharmacology , urology , compliance (psychology) , concomitant , alternative medicine , pathology , obesity , psychology , social psychology
Combining statins with antihypertensive therapy has been demonstrated to provide an early reduction in cardiovascular events. This nested substudy of the AVALON trial assessed the effects of coadministered amlodipine and atorvastatin vs. either therapy alone or placebo on arterial compliance, to evaluate the vascular benefits of coadministered therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom